Home / Pipeline / Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg + Placebo Products Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg + Placebo
Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg + Placebo Phase 1 Completed 💤 Quiet Interest: 26/100
Mar 1, 2009 → Jul 1, 2010
About Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg + Placebo Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg + Placebo is a phase 1 stage product being developed by Bayer for Pharmacology, Clinical. The current trial status is completed. This product is registered under clinical trial identifier NCT00855660. Target conditions include Pharmacology, Clinical.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT00855660 Phase 1 Completed Mar 1, 2009 Jul 1, 2010 Pharmacology, Clinical
Product Company Stage Hype Score Fluconazole (BAYT006267) 150 mg capsules + Fluconazole 150 mg capsules (DiflucanTM) Bayer Phase 1 Finerenone (BAY 94-8862) PEG solution + Finerenone (BAY 94-8862) immediate release tablet + Eplerenone (Inspra®) + Placebo Bayer Phase 1 Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated form Bayer Phase 1 Naproxen sodium and diphenhydramine hydrochloride soft capsules + Naproxen sodium and diphenhydramine hydrochloride coated tablets (Aleve PM, BAY98-7111) Bayer Phase 1 Nifedipine gastrointestinal therapeutic system (GITS) (Adalat LA, BAY a1040) + Candesartan cilexetil Bayer Phase 1 Fosrenol ODT (Lanthanum Carbonate, BAY77-1931) + Fosrenol chewable Tablet (Lanthanum Carbonate, BAY77-1931) Bayer Phase 1 Neladenoson bialanate (BAY 1067197) Bayer Phase 1 Riociguat (Adempas, BAY 63-2521) Bayer Phase 1 Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated form Bayer Phase 1 Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG) + Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-Heist) Bayer Phase 1 Riociguat (Adempas, BAY 63-2521) Bayer Phase 1 Riociguat (BAY63-2521) + Riociguat (BAY63-2521) + Riociguat (BAY63-2521) + Riociguat (BAY63-2521) + Riociguat (BAY63-2521) Bayer Phase 1 Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG) + Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-Heist) Bayer Phase 1 Neladenoson bialanate (BAY 1067197) Bayer Phase 1 BAY 98-7079, Estradiolvalerate (EV) / Dienogest (DNG) / Levomefolate calcium + BAY 86-5027,Estradiolvalerate(EV) / Dienogest (DNG) + BAY 86-7660,levomefolate calcium Bayer Phase 1 Aspirin (Acetylsalicylic acid, BAYe4465) + Aspirin (Acetylsalicylic acid, BAYe4465) + Aspirin (Acetylsalicylic acid, BAYe4465) Bayer Phase 1